BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 16297997)

  • 21. Association of leukocyte count with varying degrees of glucose intolerance in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-26).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    Metab Syndr Relat Disord; 2009 Jun; 7(3):205-10. PubMed ID: 19284318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
    Alvarsson M; Hilding A; Ostenson CG
    Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness.
    Lopez X; Bouché C; Tatro E; Goldfine AB
    Diabetes Obes Metab; 2009 Feb; 11(2):123-30. PubMed ID: 18518893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects.
    Sanyal D; Mukhopadhyay P; Pandit K; Mukhopadhyay S; Chowdhury S
    J Indian Med Assoc; 2009 Nov; 107(11):755-8. PubMed ID: 20469778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin sensitivity and beta cell function in different glucose tolerance status].
    Gómez-García A; Magaña-Garns P; Ruiz-García J; Alvarez-Aguilar C
    Invest Clin; 2006 Jun; 47(2):155-66. PubMed ID: 16886777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.
    Carnevale Schianca GP; Sainaghi PP; Castello L; Rapetti R; Limoncini AM; Bartoli E
    Diabetes Metab Res Rev; 2006; 22(2):111-7. PubMed ID: 16052601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
    Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic hemodynamics in relation to glucose tolerance: the Health 2000 Survey.
    Koivistoinen T; Jula A; Aatola H; Kööbi T; Moilanen L; Lehtimäki T; Kähönen M
    Metabolism; 2011 Apr; 60(4):557-63. PubMed ID: 20580036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
    Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-insulin dependent diabetes as an independent predictor of asymptomatic left ventricular diastolic dysfunction.
    Bajraktari G; Qirko S; Rexhepaj N; Bakalli A; Beqiri A; Elezi S; Ndrepepa G
    Croat Med J; 2005 Apr; 46(2):225-31. PubMed ID: 15849843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.